Comparative analysis of protein expression of three stem cell populations: Models of cytokine delivery system in vivo, International Journal of Pharmaceutics, vol.440, issue.1, pp.440-72, 2013. ,
DOI : 10.1016/j.ijpharm.2011.12.041
URL : https://hal.archives-ouvertes.fr/inserm-00802595
Mesenchymal Stem Cells Secrete Multiple Cytokines That Promote Angiogenesis and Have Contrasting Effects on Chemotaxis and Apoptosis, PLoS ONE, vol.3, issue.4, pp.1-8, 2012. ,
DOI : 10.1371/journal.pone.0035685.t002
A Long-Term Follow-Up Study of Intravenous Autologous Mesenchymal Stem Cell Transplantation in Patients With Ischemic Stroke, STEM CELLS, vol.25, issue.Suppl, pp.1099-1106, 2010. ,
DOI : 10.1093/jnen/63.1.84
Mesenchymal stem cells: a new trend for cell therapy, Acta Pharmacologica Sinica, vol.15, issue.6, pp.747-754, 2013. ,
DOI : 10.1038/nm.1905
Mesenchymal stem and progenitor cells: problems, potential and promise, J. Stem Cells Res. Rev. Rep, vol.1, issue.4, pp.2014-1016 ,
Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential, Journal of Cell Science, vol.117, issue.14, pp.2971-2981, 2004. ,
DOI : 10.1242/jcs.01103
Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons, Bone, vol.40, issue.2, pp.360-373, 2007. ,
DOI : 10.1016/j.bone.2006.09.013
Low Oxygen Modulates Multiple Signaling Pathways, Increasing Self-Renewal, While Decreasing Differentiation, Senescence, and Apoptosis in Stromal MIAMI Cells, Stem Cells and Development, vol.25, issue.11, pp.848-860, 2016. ,
DOI : 10.1089/scd.2015.0362
URL : http://europepmc.org/articles/pmc4892221?pdf=render
Human marrow-isolated adult multilineage-inducible (MIAMI) cells protect against peripheral vascular ischemia in a mouse model, Cytotherapy, vol.13, issue.2, pp.179-192, 2011. ,
DOI : 10.3109/14653249.2010.515579
EGF and bFGF pretreatment enhances neural specification and the response to neuronal commitment of MIAMI cells, Differentiation, vol.80, pp.4-5, 2010. ,
DOI : 10.1016/j.diff.2010.07.001
Adult cell therapy for brain neuronal damages and the role of tissue engineering, Biomaterials, vol.31, issue.8, pp.2105-2120, 2010. ,
DOI : 10.1016/j.biomaterials.2009.11.084
Defining and designing polymers and hydrogels for neural tissue engineering, Neuroscience Research, vol.72, issue.3, pp.199-213, 2012. ,
DOI : 10.1016/j.neures.2011.12.005
URL : http://europepmc.org/articles/pmc3408056?pdf=render
Nano and microcarriers to improve stem cell behaviour for neuroregenerative medicine strategies: Application to Huntington's disease, Biomaterials, vol.83, pp.347-362, 2016. ,
DOI : 10.1016/j.biomaterials.2015.12.008
Pharmacologically active microcarriers: a tool for cell therapy, Biomaterials, vol.26, issue.17, pp.3727-3737, 2005. ,
DOI : 10.1016/j.biomaterials.2004.09.042
Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival, Journal of Cellular and Molecular Medicine, vol.2, issue.11 Suppl., pp.192-204, 2013. ,
DOI : 10.1517/17425247.2.2.363
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1582-4934.2012.01662.x/pdf
Pharmacologically active microcarriers for endothelial progenitor cell support and survival, European Journal of Pharmaceutics and Biopharmaceutics, vol.81, issue.3, pp.609-616, 2012. ,
DOI : 10.1016/j.ejpb.2012.04.014
New PLGA???P188???PLGA matrix enhances TGF-??3 release from pharmacologically active microcarriers and promotes chondrogenesis of mesenchymal stem cells, Journal of Controlled Release, vol.170, issue.1, pp.99-110, 2013. ,
DOI : 10.1016/j.jconrel.2013.04.017
URL : https://hal.archives-ouvertes.fr/hal-00881128
Neuroprotective properties of marrow-isolated adult multilineage-inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers, Journal of Neurochemistry, vol.1310, issue.6, pp.972-988, 2011. ,
DOI : 10.1016/j.brainres.2009.11.012
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2011.07272.x/pdf
The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats, Biomaterials, vol.32, issue.6, pp.1560-1573, 2011. ,
DOI : 10.1016/j.biomaterials.2010.10.041
URL : https://hal.archives-ouvertes.fr/inserm-00541842
Survival, Differentiation, and Neuroprotective Mechanisms of Human Stem Cells Complexed With Neurotrophin-3-Releasing Pharmacologically Active Microcarriers in an Ex Vivo Model of Parkinson's Disease, STEM CELLS Translational Medicine, vol.17, issue.6, pp.670-684, 2015. ,
DOI : 10.1007/s10495-011-0679-9
Potential therapeutic uses of BDNF in neurological and psychiatric disorders, Cattaneo, Brain-derived neurotrophic factor in neurodegenerative diseases, pp.209-219, 2009. ,
DOI : 10.1016/j.ymthe.2005.01.007
Direct brain infusion of glial cell line???derived neurotrophic factor in Parkinson disease, Nature Medicine, vol.5, issue.Suppl. 1, pp.589-595, 2003. ,
DOI : 10.1038/jcbfm.1985.87
Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres, European Journal of Pharmaceutics and Biopharmaceutics, vol.70, issue.1, pp.127-136, 2008. ,
DOI : 10.1016/j.ejpb.2008.03.006
Pharmacologically active microcarriers associated with thermosensitive hydrogel as a growth factor releasing biomimetic 3D scaffold for cardiac tissue-engineering, Journal of Controlled Release, vol.192, pp.82-94, 2014. ,
DOI : 10.1016/j.jconrel.2014.06.052
The influence of hydrogel modulus on the proliferation and differentiation of encapsulated neural stem cells, Biomaterials, vol.30, issue.27, pp.4695-4699, 2009. ,
DOI : 10.1016/j.biomaterials.2009.05.050
Synthesis and general properties of silated-hydroxypropyl methylcellulose in prospect of biomedical use, Advances in Colloid and Interface Science, vol.99, issue.3, pp.215-228, 2002. ,
DOI : 10.1016/S0001-8686(02)00035-0
URL : https://hal.archives-ouvertes.fr/inserm-00198799
The Effect of Two- and Three-Dimensional Cell Culture on the Chondrogenic Potential of Human Adipose-Derived Mesenchymal Stem Cells after Subcutaneous Transplantation with an Injectable Hydrogel, Cell Transplantation, vol.7, issue.10, pp.1575-1588, 2011. ,
DOI : 10.1089/107632701300062859
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol, vol.3, issue.7, pp.1-12, 2002. ,
Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury, Bone Marrow Transplantation, vol.8, issue.7, pp.609-619, 2007. ,
DOI : 10.1093/jnen/64.1.37
Combining Polymeric Devices and Stem Cells for the Treatment of Neurological Disorders: A Promising Therapeutic Approach, Current Drug Targets, vol.6, issue.1, pp.81-96, 2005. ,
DOI : 10.2174/1389450053344885
How to achieve sustained and complete protein release from PLGA-based microparticles?, International Journal of Pharmaceutics, vol.350, issue.1-2, pp.1-2, 2008. ,
DOI : 10.1016/j.ijpharm.2007.11.012
URL : https://hal.archives-ouvertes.fr/inserm-00258087
Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique, European Journal of Pharmaceutics and Biopharmaceutics, vol.75, issue.2, pp.128-136, 2010. ,
DOI : 10.1016/j.ejpb.2010.03.005
URL : https://hal.archives-ouvertes.fr/hal-00626154
Poloxamer 188 Protects Neurons against Ischemia/Reperfusion Injury through Preserving Integrity of Cell Membranes and Blood Brain Barrier, PLoS ONE, vol.10, issue.4, pp.1-11, 2013. ,
DOI : 10.1371/journal.pone.0061641.g006
URL : https://doi.org/10.1371/journal.pone.0061641
Neuroprotective effect of the surfactant poloxamer 188 in a model of intracranial hemorrhage in rats, Journal of Neurosurgery: Pediatrics, vol.41, issue.1, pp.36-40, 2007. ,
DOI : 10.1016/S0304-3940(00)00971-X
Using Polymer Chemistry to Modulate the Delivery of Neurotrophic Factors from Degradable Microspheres: Delivery of BDNF, Pharmaceutical Research, vol.1, issue.1, pp.82-91, 2010. ,
DOI : 10.1016/0168-3659(94)90263-1
The rheological properties of silated hydroxypropylmethylcellulose tissue engineering matrices, Biomaterials, vol.29, issue.5, pp.533-543, 2008. ,
DOI : 10.1016/j.biomaterials.2007.10.032
URL : https://hal.archives-ouvertes.fr/inserm-00383358
Substrate Modulus Directs Neural Stem Cell Behavior, Biophysical Journal, vol.95, issue.9, pp.4426-4438, 2008. ,
DOI : 10.1529/biophysj.108.132217
URL : https://doi.org/10.1529/biophysj.108.132217
Control of three-dimensional substrate stiffness to manipulate mesenchymal stem cell fate toward neuronal or glial lineages, Acta Biomaterialia, vol.9, issue.2, pp.5170-5180, 2013. ,
DOI : 10.1016/j.actbio.2012.10.012
Probing Relevant Molecules in Modulating the Neurite Outgrowth of Hippocampal Neurons on Substrates of Different Stiffness, PLoS ONE, vol.110, issue.12, pp.1-8, 2013. ,
DOI : 10.1371/journal.pone.0083394.s004
Nanocomposite hydrogels for cartilage tissue engineering: mesoporous silica nanofibers interlinked with siloxane derived polysaccharide, Journal of Materials Science: Materials in Medicine, vol.26, issue.256, pp.24-1875, 2013. ,
DOI : 10.1016/j.biomaterials.2005.04.057
URL : https://hal.archives-ouvertes.fr/hal-00980258
Runx transcription factors: Lineage-specific regulators of neuronal precursor cell proliferation and post-mitotic neuron subtype development, Journal of Cellular Biochemistry, vol.303, issue.6, pp.1063-1072, 2009. ,
DOI : 10.1615/CritRevEukarGeneExpr.v16.i1.30
The in vivo degradation of a ruthenium labelled polysaccharide-based hydrogel for bone tissue engineering, Biomaterials, vol.30, issue.8, pp.1568-1577, 2009. ,
DOI : 10.1016/j.biomaterials.2008.11.031
URL : https://hal.archives-ouvertes.fr/inserm-00352650
In vitro and in vivo neurogenic potential of mesenchymal stem cells isolated from different sources, Journal of Biosciences, vol.30, issue.1, pp.157-169, 2014. ,
DOI : 10.1016/j.ijdevneu.2012.05.006
Hepatocyte growth factor mediates mesenchymal stem cell???induced recovery in multiple sclerosis models, Nature Neuroscience, vol.34, issue.6, pp.862-870, 2012. ,
DOI : 10.1016/j.exphem.2006.07.014
URL : http://europepmc.org/articles/pmc3427471?pdf=render
Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: Focusing on neuroprotective effects of stromal cell-derived factor-1??, BMC Neuroscience, vol.11, issue.1, pp.1-9, 2010. ,
DOI : 10.1186/1471-2202-11-52
Erythropoietin promotes axonal growth in a model of neuronal polarization, Molecular and Cellular Neuroscience, vol.38, issue.4, pp.537-547, 2008. ,
DOI : 10.1016/j.mcn.2008.05.002
Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro, European Journal of Neuroscience, vol.19, issue.2, pp.457-466, 2000. ,
DOI : 10.1016/S0091-6749(99)70125-9
VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection, BioEssays, vol.358, issue.9, pp.943-954, 2004. ,
DOI : 10.1016/S0140-6736(01)06260-2
Expansion and Delivery of Adipose-Derived Mesenchymal Stem Cells on Three Microcarriers for Soft Tissue Regeneration, Tissue Engineering Part A, vol.17, issue.23-24, pp.23-24, 2011. ,
DOI : 10.1089/ten.tea.2010.0707
Engineering stem cell fate with biochemical and biomechanical properties of microcarriers, Biotechnology Progress, vol.16, issue.6, pp.1354-1366, 2013. ,
DOI : 10.1089/ten.tea.2009.0454
The role of ???anti-inflammatory??? cytokines in axon regeneration, Cytokine & Growth Factor Reviews, vol.24, issue.1, pp.1-12, 2013. ,
DOI : 10.1016/j.cytogfr.2012.08.008
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease, Nature Medicine, vol.109, issue.3, pp.331-337, 2009. ,
DOI : 10.1016/0028-3932(91)90063-E
Effects of Brain-derived Neurotrophic Factor on 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in Monkeys, Neurosurgery, vol.59, issue.4, pp.739-741, 1995. ,
DOI : 10.1111/j.1471-4159.1992.tb09429.x
Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6/2 mouse model of Huntington's disease, PLoS One, vol.8, issue.5, pp.1-12, 2013. ,
Alberch, Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction, Mol. Neurodegener, vol.6, issue.1, pp.1-16, 2011. ,
DOI : 10.1186/1750-1326-6-71
URL : https://doi.org/10.1186/1750-1326-6-71